Clinical Trial Update: Aromatase Inhibitors for Treatment of Uterine Leiomyomas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of aromatase inhibitors for treating uterine fibroids has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Symptomatic or Large Uterine Fibroids | Phase 1 | Status: WITHDRAWN